Back
Moderna 10K Form
Sell
37
MRNA
Moderna
Last Price:
78.23
Seasonality Move:
39.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MRNA News And Ratings
See the #1 stock for the next 7 days that we like better than MRNA
MRNA Financial Statistics
Sales & Book Value
| Annual Sales: | $18.88B |
|---|---|
| Cash Flow: | $-1.74B |
| Price / Cash Flow: | 0 |
| Annual Sales: | $35.32 |
| Price / Book: | 2.22 |
Profitability
| EPS (TTM): | -9.35000 |
|---|---|
| Net Income (TTM): | $-3.47B |
| Gross Margin: | $13.46B |
| Return on Equity: | -20.06% |
| Return on Assets: | -14.77% |
Moderna Earnings Forecast
Key Moderna Financial Ratios
- The Gross Profit Margin over the past 29 years for MRNA is 71.31%.
- The Selling, General & Administrative Expenses for MRNA have been equal to 6.00% of Gross Profit Margin.
- The Research & Development expenses have been 17.46% of Revenue.
- The Interest Expense is 0.35% of Operating Income.
- The Net Earning history of MRNA is 44.30% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 14 years.
Moderna Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | MRNA |
| CUSIP: | 60770K |
| Website: | modernatx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.46 |
| Quick Ratio: | 2.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 3.89 |
|---|---|
| Forward P/E Ratio: | 0 |